twitter test

Article

Can circulating tumor DNA predict relapse in breast cancer?

- Dr. Muin Khoury (@DrKhouryCDC) August 30, 2015

Cool technology. Not quite ready for primetime but soon. Blood test could predict breast cancer relapse @cbsnews

- Hal Burstein, MD (@DrHBurstein) August 27, 2015

MT @NEJM: Daratumumab elicited impressive responses in pretreated myeloma pts. #mmsm

- Michael Fisch (@fischmd) August 27, 2015

Daratumumab is safe and has encouraging activity in patients with heavily pretreated and refractory myeloma

- Muzaffar Qazilbash (@Transplant_Doc) August 26, 2015

Recent Videos
Retrospective and real-world registry studies may be necessary to guide clinical decision-making for rarer lymphomas with insufficient prospective data.
Extravasation results in exposing healthy tissue to radiation, which can be highly dosed depending on the isotope used for treatment.
4 experts in this video
2 experts in this video
2 experts in this video
4 experts in this video
Ongoing studies seek to evaluate immunotherapy in earlier lines of therapy for patients with early-stage Hodgkin lymphoma.
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
Related Content